2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$108.99+$0.19 (+0.17%)
Price as of Aug 21, 2026 7:30 PM EDT- $5.0BMarket Cap
- 93.01%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$108.99+$0.19 (+0.17%)
HAE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $108.80 | ||
Change | +$0.58 (+0.54%) | ||
Open | $109.24 | ||
High | $109.57 | ||
Low | $107.00 | ||
Previous Close | $108.22 | ||
Volume | 582,115 | ||
30-Day Average Volume | 863,983 | ||
1-Week Change | 19.82% | ||
1-Month Change | 39.36% | ||
1-Year Change | 93.01% | ||
3-Year Change | 27.33% | ||
5-Year Change | 82.49% | ||
Fundamentals | |||
Shares Outstanding | 45.5M | ||
Total Assets | $2.4B | ||
Market Cap | $5.0B | ||
Enterprise Value | $5.9B | ||
Period: QTR TTM FY | |||
Revenue | $339.4M | ||
Net Income | $33.0M | ||
Free Cash Flow | $44.4M | ||
EBIT | $52.8M | ||
EBITDA | $79.9M | ||
Net Working Capital | $547.6M | ||
EPS | $0.72 | ||
Enterprise Value/EBITDA | 74 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 6 | ||
P/E | 151 | ||
PEG | 1 | ||
Price/Free Cash Flow | 111 | ||
Price/Operating Cash Flow | 95 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/03/2012 | ||
Earnings & Revenue